Inhibitory Effects of Glucosylceramide on Tumorigenesis Induced by a Carcinogen in Mice

Overview

Journal Laryngoscope

Specialty Otorhinolaryngology

Date 2019 Dec 7

PMID 31808958

Citations 3

Authors

Kazunori Fujiwara

Hiroaki Yazama

Ryouhei Donishi

Satoshi Koyama

Takahiro Fukuhara

Hiromi Takeuchi

Affiliations

Soon will be listed here.

Abstract

Objective: Glucosylceramide (Glu-Cer), a glycosylated form of ceramide, has been reported to have cytotoxic effects in the cells of various cancers. We previously reported that dietary Glu-Cer from rice bran had inhibitory effects on human head and neck squamous cell carcinoma (HNSCC) in nonobese diabetes (NOD)/severe combined immunodeficiency (SCID) mice. In HNSCC, preventing recurrence and second primary cancer is required to improve prognosis. The purpose of the present study was to determine whether dietary Glu-Cer had anticarcinogenic and antitumorigenic effects in a mouse model of HNSCC.

Methods: A total of 40 CB6F1-Tg rasH2@Jcl mice were divided into two groups: control and Glu-Cer. All mice were given 4-nitroquinoline 1-oxide for 24 weeks. Control group mice were fed the normal diet without Glu-Cer. The Glu-Cer group mice were given a mixture of the normal diet plus 0.25% Glu-Cer for 24 weeks. Microscopic examination was performed to identify grossly visible preneoplasms and neoplasms in the mouth, pharynx, and esophagus. Epithelial regions were classified as normal tissue, carcinoma in situ (CIS), or SCC; and the number of each type of region was counted.

Results: Compared with the Glu-Cer group mice, control group mice more frequently developed individual and multiple tumors of each type, including CIS and SCC, in the mouth, pharynx, or esophagus.

Conclusion: Tumor development was effectively inhibited by dietary Glu-Cer derived from rice bran, indicating that this and related compounds show promise as prophylactic agents for human HNSCC.

Level Of Evidence: NA Laryngoscope, 130:E593-E597, 2020.

Citing Articles

A Decrease in the Hardness of Feces with Added Glucosylceramide Extracted from Koji -A Working Hypothesis of Health Benefits of Dietary Glucosylceramide.

Dai H, Hariwitonang J, Fujiyama N, Moriguchi C, Hirano Y, Ebara F Life (Basel). 2024; 14(6).

PMID: 38929722 PMC: 11204706. DOI: 10.3390/life14060739.

Glucosylceramide Changes Bacterial Metabolism and Increases Gram-Positive Bacteria through Tolerance to Secondary Bile Acids In Vitro.

Dai H, Otsuka A, Tanabe K, Yanagita T, Nakayama J, Kitagaki H Int J Mol Sci. 2022; 23(10).

PMID: 35628110 PMC: 9141989. DOI: 10.3390/ijms23105300.

Dietary Sphingolipids Contribute to Health via Intestinal Maintenance.

Yamashita S, Kinoshita M, Miyazawa T Int J Mol Sci. 2021; 22(13).

PMID: 34208952 PMC: 8268314. DOI: 10.3390/ijms22137052.

References

Okazaki T, Bell R, Hannun Y . Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem. 1989; 264(32):19076-80. View

Manoharan S, Balakrishnan S, Menon V, Alias L, Reena A . Chemopreventive efficacy of curcumin and piperine during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Singapore Med J. 2009; 50(2):139-46. View

Oku H, Wongtangtintharn S, Iwasaki H, Inafuku M, Shimatani M, Toda T . Tumor specific cytotoxicity of glucosylceramide. Cancer Chemother Pharmacol. 2007; 60(6):767-75. DOI: 10.1007/s00280-007-0422-y. View

Han C, Ding H, Casto B, Stoner G, DAmbrosio S . Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries. Nutr Cancer. 2005; 51(2):207-17. DOI: 10.1207/s15327914nc5102_11. View

Kolesnick R, Kronke M . Regulation of ceramide production and apoptosis. Annu Rev Physiol. 1998; 60:643-65. DOI: 10.1146/annurev.physiol.60.1.643. View

Hasina R, Martin L, Kasza K, Jones C, Jalil A, Lingen M . ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. Cancer Prev Res (Phila). 2009; 2(4):385-93. PMC: 2702843. DOI: 10.1158/1940-6207.CAPR-08-0211. View

Inafuku M, Li C, Kanda Y, Kawamura T, Takeda K, Oku H . Beta-glucosylceramide administration (i.p.) activates natural killer T cells in vivo and prevents tumor metastasis in mice. Lipids. 2012; 47(6):581-91. DOI: 10.1007/s11745-012-3666-1. View

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J, Comber H . Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6):1374-403. DOI: 10.1016/j.ejca.2012.12.027. View

Tanaka T, Kojima T, Okumura A, Yoshimi N, Mori H . Alterations of the nucleolar organizer regions during 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats. Carcinogenesis. 1991; 12(2):329-33. DOI: 10.1093/carcin/12.2.329. View

10.

Hashibe M, Brennan P, Chuang S, Boccia S, Castellsague X, Chen C . Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009; 18(2):541-50. PMC: 3051410. DOI: 10.1158/1055-9965.EPI-08-0347. View

11.

Suzuki R, Kohno H, Suzui M, Yoshimi N, Tsuda H, Wakabayashi K . An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies. Carcinogenesis. 2005; 27(3):619-30. DOI: 10.1093/carcin/bgi241. View

12.

Fujiwara K, Kitatani K, Fukushima K, Yazama H, Umehara H, Kikuchi M . Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice. Int J Clin Oncol. 2010; 16(2):133-40. DOI: 10.1007/s10147-010-0141-y. View

13.

Lippman S, Hong W . Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989; 17(3):691-4. DOI: 10.1016/0360-3016(89)90126-0. View

14.

Lindsay C, Seikaly H, Biron V . Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets. J Otolaryngol Head Neck Surg. 2017; 46(1):9. PMC: 5282807. DOI: 10.1186/s40463-017-0185-3. View

15.

Vesper H, Schmelz E, Nikolova-Karakashian M, Dillehay D, Lynch D, Merrill Jr A . Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr. 1999; 129(7):1239-50. DOI: 10.1093/jn/129.7.1239. View

16.

Inamine M, Suzui M, Morioka T, Kinjo T, Kaneshiro T, Sugishita T . Inhibitory effect of dietary monoglucosylceramide 1-O-beta-glucosyl-N-2'-hydroxyarachidoyl-4,8-sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 rats. Cancer Sci. 2005; 96(12):876-81. PMC: 11158130. DOI: 10.1111/j.1349-7006.2005.00127.x. View

17.

Harish Kumar G, Vidya Priyadarsini R, Vinothini G, Letchoumy P, Nagini S . The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis. Invest New Drugs. 2009; 28(4):392-401. DOI: 10.1007/s10637-009-9263-3. View

18.

Hong W, Endicott J, Itri L, Doos W, BATSAKIS J, Bell R . 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986; 315(24):1501-5. DOI: 10.1056/NEJM198612113152401. View

19.

Hannun Y, Obeid L . Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008; 9(2):139-50. DOI: 10.1038/nrm2329. View

20.

Sathyan K, Nalinakumari K, Abraham T, Kannan S . Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol. 2006; 42(6):607-13. DOI: 10.1016/j.oraloncology.2005.10.019. View